Gaurav Aggarwal
CIK 1551965 · Chief Business Officer · last filed 2025-08-26
Gaurav Aggarwal is a Chief Business Officer who has filed 23 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for UNCY, was dated Aug 26, 2025. Across all open-market trades the lifetime net is +$21.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $13.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.98M
4
23
$21.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNCY | Director | 1,789,915 | $7.25 | $12.98M | $0 | 7 | 2025-08-26 |
| GERN | Director | 1,970 | $1.15 | $2.3K | $0 | 4 | 2025-05-22 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $21.60M | 7 | 2022-07-01 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | Director | 5,000 | — | — | $50.0K | 1 | 2012-08-02 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-26 | UNCY | Mixed | +652,900 | $0 | EDGAR |
| 2025-07-30 | UNCY | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | GERN | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | UNCY | Mixed | +1,400,000 | $0 | EDGAR |
| 2024-10-10 | UNCY | Mixed | +5,500,000 | $0 | EDGAR |
| 2024-05-10 | GERN | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | GERN | Grant (A) | +1,970 | $0 | EDGAR |
| 2023-11-28 | GERN | Grant (A) | — | $0 | EDGAR |
| 2023-09-07 | UNCY | Grant (A) | — | $0 | EDGAR |
| 2023-07-13 | UNCY | Conv (C) | +3,470,152 | $0 | EDGAR |